Averdunk, L.; Fitzner, C.; Levkovich, T.; Leaf, D.E.; Sobotta, M.; Vieten, J.; Ochi, A.; Moeckel, G.; Marx, G.; Stoppe, C.
Secretory Leukocyte Protease Inhibitor (SLPI)—A Novel Predictive Biomarker of Acute Kidney Injury after Cardiac Surgery: A Prospective Observational Study. J. Clin. Med. 2019, 8, 1931.
https://doi.org/10.3390/jcm8111931
AMA Style
Averdunk L, Fitzner C, Levkovich T, Leaf DE, Sobotta M, Vieten J, Ochi A, Moeckel G, Marx G, Stoppe C.
Secretory Leukocyte Protease Inhibitor (SLPI)—A Novel Predictive Biomarker of Acute Kidney Injury after Cardiac Surgery: A Prospective Observational Study. Journal of Clinical Medicine. 2019; 8(11):1931.
https://doi.org/10.3390/jcm8111931
Chicago/Turabian Style
Averdunk, Luisa, Christina Fitzner, Tatjana Levkovich, David E. Leaf, Michael Sobotta, Jil Vieten, Akinobu Ochi, Gilbert Moeckel, Gernot Marx, and Christian Stoppe.
2019. "Secretory Leukocyte Protease Inhibitor (SLPI)—A Novel Predictive Biomarker of Acute Kidney Injury after Cardiac Surgery: A Prospective Observational Study" Journal of Clinical Medicine 8, no. 11: 1931.
https://doi.org/10.3390/jcm8111931
APA Style
Averdunk, L., Fitzner, C., Levkovich, T., Leaf, D. E., Sobotta, M., Vieten, J., Ochi, A., Moeckel, G., Marx, G., & Stoppe, C.
(2019). Secretory Leukocyte Protease Inhibitor (SLPI)—A Novel Predictive Biomarker of Acute Kidney Injury after Cardiac Surgery: A Prospective Observational Study. Journal of Clinical Medicine, 8(11), 1931.
https://doi.org/10.3390/jcm8111931